| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
Purity: ≥98%
| Targets |
hCB1-R ( pKi = 7.93 ); hCB2-R ( pKi = 9.06 )
|
|---|---|
| ln Vitro |
AZD1940 exhibits complete agonism at both receptors in all three species after binding with high affinity to the CB1 and CB2 receptors in humans, rats, and mice[1][2].
|
| ln Vivo |
AZD1940 exhibits a strong analgesic effect in a variety of inflammatory and neuropathic pain models when administered orally to rats[1][2]. It has been shown that rats and primates exhibit low brain uptake of AZD1940 at analgesic doses[1].
|
| References |
|
| Molecular Formula |
C20H29F2N3O2S
|
|---|---|
| Molecular Weight |
413.52
|
| Exact Mass |
413.195
|
| Elemental Analysis |
C, 58.09; H, 7.07; F, 9.19; N, 10.16; O, 7.74; S, 7.75
|
| CAS # |
881413-29-2
|
| Related CAS # |
881413-29-2
|
| PubChem CID |
11675994
|
| Appearance |
White to off-white solid powder
|
| LogP |
6.074
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
28
|
| Complexity |
635
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O=S(CC)(NC1C=C2N=C(C(C)(C)C)N(C2=CC=1)CC1CCC(F)(F)CC1)=O
|
| InChi Key |
ZAGGGZCIFUQHOH-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C20H29F2N3O2S/c1-5-28(26,27)24-15-6-7-17-16(12-15)23-18(19(2,3)4)25(17)13-14-8-10-20(21,22)11-9-14/h6-7,12,14,24H,5,8-11,13H2,1-4H3
|
| Chemical Name |
N-[2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]benzimidazol-5-yl]ethanesulfonamide
|
| Synonyms |
AZD-1940; AZD 1940; AZD1940; UNII-0J0035E9FT; ART-27.13; ART 27.13; ART27.13; ART-2713; ART 2713; ART2713
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~100 mg/mL (~241.8 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.05 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.05 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4183 mL | 12.0913 mL | 24.1826 mL | |
| 5 mM | 0.4837 mL | 2.4183 mL | 4.8365 mL | |
| 10 mM | 0.2418 mL | 1.2091 mL | 2.4183 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
| NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
| NCT00689780 | Completed | Drug: AZD1940 Drug: Midazolam |
Low Back Pain | AstraZeneca | March 2008 | Phase 1 |
| NCT00659490 | Completed | Drug: AZD1940 Drug: Naproxen |
Pain | AstraZeneca | February 2008 | Phase 2 |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA